ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.

about

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.

Item

http://www.wikidata.org/entity/Q55435917

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@en

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@nl

type

Item

label

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@en

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@nl

prefLabel

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@en

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@nl

P1476

ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.

@en

P2093

Bin Chen

http://www.w3.org/2001/XMLSchema#string

Jiao Zou

http://www.w3.org/2001/XMLSchema#string

Linlin Zhu

http://www.w3.org/2001/XMLSchema#string

Xiangwei Wang

http://www.w3.org/2001/XMLSchema#string

Xiaomei Jiang

http://www.w3.org/2001/XMLSchema#string

Yang Wang

http://www.w3.org/2001/XMLSchema#string

Yuanyin Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells

EGF-ERBB signalling: towards the systems level

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.

Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.

RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy

ER-α36: a novel biomarker and potential therapeutic target in breast cancer.

Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells

Cisplatin: from DNA damage to cancer chemotherapy.

A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells

P2888

s13046-018-0798-z

P304

123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-018-0798-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105096559

http://www.w3.org/2001/XMLSchema#string

P698

29940998

http://www.w3.org/2001/XMLSchema#string

P932

6019204

http://www.w3.org/2001/XMLSchema#string